Work

Mechanistic static modeling predicts low risk of unconjugated hyperbilirubinemia due to UGT1A1 inhibition by pirtobrutinib 200 mg once daily

Year: 2024

Type: article

Source: Drug Metabolism and Pharmacokinetics

DOI: 10.1016/j.dmpk.2023.100889

Authors: Jessica Rehmel, Maria Posada, Kathleen Hillgren, Nita Patel, Stephen Hall

Institution: Eli Lilly (United States)

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4396850873

FWCI:

Cites:

Cited by:

Related to: 10